Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHF8 | Q9UPP1 | 6/20 | 0.65 |
| ▸ | KDM2A | Q9Y2K7 | 6/20 | 0.65 |
| ▸ | EGLN1 | Q9GZT9 | 5/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.65 |
| ▸ | KDM5C | P41229 | 4/20 | 0.65 |
| ▸ | KDM6B | O15054 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.60 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.60 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.55 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | LDHA | P00338 | 1/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.45 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218098 | 1.00 | PHF8 (0.65) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377444 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377423 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377434 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| Ammonia Solution, Strong SCHEMBL20377426 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377443 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL6914036 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377429 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377438 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| Hydrogen Sulfide SCHEMBL28240428 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215461-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | TORAY INDUSTRIES, INC. (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4497819-A1 | GENETICALLY-MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | Toray Industries, Inc. (JP) | 2025-01-29 | — | — | EP | disclosed |
| WO-2023182322-A1 | GENETICALLY-MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | 東レ株式会社 | 2023-09-28 | — | — | WO | disclosed |
| US-11753662-B2 | Method for producing 3-Oxoadipic acid | TORAY INDUSTRIES, INC. (JP) | 2023-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215461-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | HMGCR, GNPAT, COASY | PHF8 3620/4885KDM2A 3817/4885EGLN1 3294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.